Privia Health
PRVA
234 hedge funds and large institutions have $2.85B invested in Privia Health in 2023 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 99 increasing their positions, 44 reducing their positions, and 27 closing their positions.
225% more call options, than puts
Call options by funds: $4.96M | Put options by funds: $1.52M
163% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 27
125% more repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 44
28% more capital invested
Capital invested by funds: $2.23B → $2.85B (+$619M)
24.04% more ownership
Funds ownership: 70.38% → 94.43% (+24%)
23% more funds holding
Funds holding: 191 → 234 (+43)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$345M |
| 2 |
BlackRock
New York
|
+$246M |
| 3 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
+$240M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$143M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$122M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$655M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$70.3M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$28.9M |
| 4 |
Morgan Stanley
New York
|
-$17.9M |
| 5 |
Renaissance Technologies
New York
|
-$8.68M |
PRVA Hedge Fund Activity: Q2 2023 in Review
234 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Privia Health (PRVA) for Q2 2023, worth a combined $2.85B — up 28% from $2.23B a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new PRVA positions and 27 closed out — a net gain of 44 holders — while 99 added to existing stakes and 44 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $345M. The largest seller was Goldman Sachs, cutting an estimated $655M.
- 234 institutional investors held Privia Health (PRVA) as of Q2 2023, up from 191 in Q1 2023.
- Funds reported $2.85B of Privia Health stock for Q2 2023, up 28% quarter-over-quarter.
- 71 funds opened new Privia Health positions in Q2 2023 and 27 closed out, a net change of +44 holders.
- The largest Privia Health buyer in Q2 2023 was Fidelity Investments, an estimated $345M added.
- The largest Privia Health seller in Q2 2023 was Goldman Sachs, an estimated $655M sold.
Based on aggregated 13F filings for Q2 2023.